Long-Term Safety and Efficacy of Canakinumab in Cryopyrin-Associated Periodic Syndrome (CAPS) Patients: Results From Beta-Confident Registry
Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-13-s1-p3
Full Text
Open PDFAbstract
Available in full text
Date
September 28, 2015
Authors
Publisher
Springer Science and Business Media LLC